$582 Million is the total value of SENZAR ASSET MANAGEMENT, LLC's 38 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 63.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVRO | Buy | NEVRO CORP | $54,098,000 | +115.5% | 1,006,479 | +92.2% | 9.29% | +51.8% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $51,860,000 | +51.0% | 877,497 | +59.2% | 8.90% | +6.4% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $51,264,000 | +140.6% | 422,900 | +150.2% | 8.80% | +69.5% |
| STJ | Sell | ST JUDE MED INC | $41,116,000 | -14.3% | 562,700 | -23.3% | 7.06% | -39.6% |
| PRGO | New | PERRIGO CO PLC | $36,615,000 | – | 198,100 | +100.0% | 6.29% | – |
| CNCE | Buy | CONCERT PHARMACEUTICALS INC | $23,192,000 | +37.2% | 1,557,534 | +39.6% | 3.98% | -3.3% |
| BDX | New | BECTON DICKINSON & CO | $20,808,000 | – | 146,900 | +100.0% | 3.57% | – |
| HWAY | New | HEALTHWAYS INC | $17,257,000 | – | 1,440,503 | +100.0% | 2.96% | – |
| RCPT | Buy | RECEPTOS INC | $17,066,000 | +51.3% | 89,800 | +31.3% | 2.93% | +6.7% |
| MDT | New | MEDTRONIC PLC | $16,924,000 | – | 228,400 | +100.0% | 2.91% | – |
| JNJ | New | JOHNSON & JOHNSON | $16,705,000 | – | 171,400 | +100.0% | 2.87% | – |
| MYL | New | MYLAN N V | $15,865,000 | – | 233,784 | +100.0% | 2.72% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $12,583,000 | – | 153,900 | +100.0% | 2.16% | – |
| MDXG | Sell | MIMEDX GROUP INC | $12,524,000 | -42.7% | 1,080,559 | -48.6% | 2.15% | -59.6% |
| CI | New | CIGNA CORPORATION | $12,361,000 | – | 76,300 | +100.0% | 2.12% | – |
| ELOS | Buy | SYNERON MEDICAL LTD | $12,125,000 | -12.8% | 1,141,700 | +1.7% | 2.08% | -38.5% |
| OFIX | Buy | ORTHOFIX INTL N V | $11,923,000 | -3.2% | 360,001 | +4.9% | 2.05% | -31.8% |
| KND | Sell | KINDRED HEALTHCARE INC | $11,705,000 | -69.9% | 576,876 | -64.8% | 2.01% | -78.8% |
| DYAX | New | DYAX CORP | $11,671,000 | – | 440,433 | +100.0% | 2.00% | – |
| INSM | Sell | INSMED INC | $11,338,000 | +1.1% | 464,307 | -13.9% | 1.95% | -28.8% |
| CORI | Sell | CORIUM INTL INC | $11,131,000 | +67.5% | 813,085 | -19.9% | 1.91% | +18.0% |
| SGNT | Buy | SAGENT PHARMACEUTICALS INC | $11,022,000 | +13.5% | 453,392 | +8.5% | 1.89% | -20.0% |
| XNPT | Buy | XENOPORT INC | $10,556,000 | +1.8% | 1,722,100 | +18.2% | 1.81% | -28.3% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $9,318,000 | +32.8% | 859,549 | +54.6% | 1.60% | -6.4% |
| AET | New | AETNA INC NEW | $8,412,000 | – | 66,000 | +100.0% | 1.44% | – |
| ESRX | New | EXPRESS SCRIPTS HLDG CO | $8,298,000 | – | 93,300 | +100.0% | 1.42% | – |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $7,761,000 | +154.0% | 876,000 | +182.7% | 1.33% | +78.9% |
| PMC | Sell | PHARMERICA CORP | $7,633,000 | -2.2% | 229,214 | -17.2% | 1.31% | -31.0% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $7,251,000 | +37.9% | 707,449 | +24.4% | 1.24% | -2.9% |
| RTRX | Sell | RETROPHIN INC | $6,945,000 | -39.5% | 209,500 | -56.3% | 1.19% | -57.3% |
| XENT | Buy | INTERSECT ENT INC | $6,692,000 | +503.4% | 233,757 | +444.5% | 1.15% | +325.6% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $5,154,000 | +43.8% | 161,300 | +7.5% | 0.88% | +1.4% |
| AGNPRA | New | ALLERGAN PLCpfd conv ser a | $5,124,000 | – | 4,900 | +100.0% | 0.88% | – |
| ALQA | Buy | ALLIQUA BIOMEDICAL INC | $4,319,000 | +215.9% | 819,600 | +211.7% | 0.74% | +122.8% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $3,777,000 | -47.5% | 1,176,487 | -41.7% | 0.65% | -63.0% |
| ACRX | Sell | ACELRX PHARMACEUTICALS INC | $3,385,000 | -15.7% | 798,381 | -23.3% | 0.58% | -40.7% |
| BOTA | Buy | BIOTA PHARMACEUTIALS INC | $3,348,000 | -1.1% | 1,617,500 | +9.9% | 0.58% | -30.3% |
| SPNC | New | SPECTRANETICS CORP | $3,231,000 | – | 140,400 | +100.0% | 0.56% | – |
| PFNX | Exit | PFENEX INC | $0 | – | -52,300 | -100.0% | -0.20% | – |
| RPRX | Exit | REPROS THERAPEUTICS INC | $0 | – | -244,006 | -100.0% | -0.51% | – |
| FLML | Exit | FLAMEL TECHNOLOGIES SAsponsored adr | $0 | – | -225,351 | -100.0% | -0.99% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -154,300 | -100.0% | -1.15% | – |
| ACTPRA | Exit | ACTAVIS PLCpfd conv ser a | $0 | – | -4,900 | -100.0% | -1.21% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -695,016 | -100.0% | -2.57% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -306,500 | -100.0% | -5.43% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -479,412 | -100.0% | -5.78% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CONCERT PHARMACEUTICALS INC | 16 | Q2 2018 | 4.5% |
| SANOFI | 14 | Q2 2018 | 17.6% |
| CORIUM INTL INC | 14 | Q3 2017 | 2.3% |
| FOAMIX PHARMACEUTICALS LTD | 14 | Q2 2018 | 2.1% |
| RETROPHIN INC | 13 | Q2 2017 | 3.0% |
| ALDER BIOPHARMACEUTICALS INC | 12 | Q2 2018 | 3.9% |
| RIGEL PHARMACEUTICALS INC | 12 | Q3 2016 | 1.8% |
| INSMED INC | 11 | Q3 2017 | 6.2% |
| TEVA PHARMACEUTICAL INDS LTD | 10 | Q1 2016 | 12.3% |
| ORTHOFIX INTL N V | 10 | Q1 2017 | 9.0% |
View SENZAR ASSET MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Corium International, Inc.Sold out | February 14, 2018 | 0 | 0.0% |
| Aviragen Therapeutics, Inc. | February 13, 2017 | 1,774,876 | 4.6% |
| CONCERT PHARMACEUTICALS, INC. | February 13, 2017 | 400,588 | 1.8% |
| Foamix Pharmaceuticals Ltd. | February 13, 2017 | 550,997 | 1.5% |
| NEVRO CORPSold out | February 13, 2017 | 0 | 0.0% |
| TIVITY HEALTH, INC. | February 13, 2017 | 383,200 | 1.0% |
| HEALTHWAYS, INC | February 12, 2016 | 2,525,044 | 7.0% |
| Sientra, Inc. | February 12, 2016 | 580,851 | 3.2% |
| Biota Pharmaceuticals, Inc. | January 15, 2016 | 2,025,976 | 5.2% |
View SENZAR ASSET MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-10-31 |
| 13F-HR | 2018-08-13 |
| 13F-HR | 2018-05-14 |
| SC 13G/A | 2018-02-14 |
| 13F-HR | 2018-02-13 |
| 13F-HR | 2017-11-13 |
| 13F-HR | 2017-08-11 |
| 13F-HR | 2017-05-12 |
| 13F-HR | 2017-02-14 |
| SC 13G/A | 2017-02-13 |
View SENZAR ASSET MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.